Literature DB >> 3127105

Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis.

O Meyer1, L Cyna, P Bourgeois, M F Kahn, A Ryckewaert.   

Abstract

Antiphospholipid antibodies have been determined in two groups of 48 sera from patients with systemic lupus erythematosus (SLE) and syphilis. Using an ELISA, IgG anticardiolipin (CL), antiphosphatidyl serine (PS) and antiphosphatidyl ethanolamine (PEA), antibodies have been detected with the same frequency in both groups of patients. Titres of antiphosphatidyl serine (PS) (p less than 0.005) and PEA antibodies (p less than 0.05) were significantly higher in the syphilitic sera compared to the SLE sera. Anticardiolipin binding activity of both groups of sera could be inhibited by preincubation with phosphatidic acid, phosphatidyl serine, phosphatidyl glycerol and cardiolipin antigens, but the inhibiting ratio of phosphatidyl antigen was significantly higher (p less than 0.01) in the SLE group. These data suggest that anticardiolipin auto-antibodies present in SLE sera are very similar to the "reagins" or antibodies to cardiolipin seen in syphilitic sera. IgG anticardiolipin antibodies may be an epiphenomenon and are probably not implicated in the pathogenesis of the thrombotic diathesis seen preferentially in some patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3127105     DOI: 10.1007/bf02206835

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Biologically false positive serologic tests for syphilis; type, incidence, and cause.

Authors:  J E MOORE; C F MOHR
Journal:  J Am Med Assoc       Date:  1952-10-04

2.  Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant.

Authors:  R Cariou; G Tobelem; C Soria; J Caen
Journal:  N Engl J Med       Date:  1986-05-01       Impact factor: 91.245

3.  [Anti-phospholipid autoantibodies].

Authors:  O Meyer
Journal:  Presse Med       Date:  1986-03-15       Impact factor: 1.228

Review 4.  Lupus anticoagulants.

Authors:  S S Shapiro; P Thiagarajan
Journal:  Prog Hemost Thromb       Date:  1982

5.  Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.

Authors:  E Angles-Cano; Y Sultan; J P Clauvel
Journal:  J Lab Clin Med       Date:  1979-08

6.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

7.  The lupus anticoagulant.

Authors:  M Boxer; L Ellman; A Carvalho
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

8.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

9.  The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA.

Authors:  C B Colaco; K B Elkon
Journal:  Arthritis Rheum       Date:  1985-01

10.  Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus.

Authors:  T Koike; M Sueishi; H Funaki; H Tomioka; S Yoshida
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

View more
  4 in total

1.  [Female patient with Sjoegren's syndrome and cardiolipin antibodies].

Authors:  S Vilardi; K Muth; M Uppenkamp; R Bergner
Journal:  Internist (Berl)       Date:  2011-06       Impact factor: 0.743

2.  Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening.

Authors:  Sung Soo Ahn; Seung Min Jung; Juyoung Yoo; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park
Journal:  Rheumatol Int       Date:  2019-08-29       Impact factor: 2.631

3.  Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilis.

Authors:  S Loizou; C G Mackworth-Young; C Cofiner; M J Walport
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.

Authors:  C Sachse; K Lüthke; K Hartung; M Fricke; B Liedvogel; J R Kalden; H H Peter; H J Lakomek; E Henkel; H Deicher
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.